Drug Interactions and Side Effects of Zometa and Protonix and Glyburide and Celebrex and Lipitor and Vicodin and Phenergan and Naprosyn and Hydrocodone Bitartrate
>>> Check drugs in a new way
| Report ID | Date of report | Patient age | Patient gender |
| 51048 | Feb, 21, 2006 | 43 | Male |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Zometa | zoledronic acid |
Protonix | pantoprazole sodium |
Glyburide | glyburide |
Celebrex | celecoxib |
Lipitor | atorvastatin calcium |
Vicodin | acetaminophen; hydrocodone bitartrate |
Phenergan | promethazine hydrochloride |
Naprosyn | naproxen |
Hydrocodone Bitartrate | hydrocodone bitartrate; ibuprofen |
| Name |
Bone Debridement |
Face Oedema |
Facial Pain |
Haemorrhage |
Headache |
Inflammation |
Jaw Fracture |
Jaw Operation |
Lymphadenopathy |
Muscle Tightness |
Osteitis |
Osteomyelitis |
Osteonecrosis |
Pain In Jaw |
Plastic Surgery |
Primary Sequestrum |
Sequestrectomy |
Stomatitis |
Tooth Disorder |
Tooth Extraction |
Wound Treatment |
Results from eHealthMe : 1 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Bone Debridement | 1 (100.00%) |
Face Oedema | 1 (100.00%) |
Facial Pain | 1 (100.00%) |
Haemorrhage | 1 (100.00%) |
Headache | 1 (100.00%) |
Inflammation | 1 (100.00%) |
Jaw Fracture | 1 (100.00%) |
Jaw Operation | 1 (100.00%) |
Lymphadenopathy | 1 (100.00%) |
Muscle Tightness | 1 (100.00%) |
Osteitis | 1 (100.00%) |
Osteomyelitis | 1 (100.00%) |
Osteonecrosis | 1 (100.00%) |
Pain In Jaw | 1 (100.00%) |
Plastic Surgery | 1 (100.00%) |
Primary Sequestrum | 1 (100.00%) |
Sequestrectomy | 1 (100.00%) |
Stomatitis | 1 (100.00%) |
Tooth Disorder | 1 (100.00%) |
Tooth Extraction | 1 (100.00%) |
Wound Treatment | 1 (100.00%) |
Top 3 (total: 0. Click here to see more) co-used drugs - potential interacting drugs:
Death reported: 0
| Name | Count (% of total reports) |
Primary Sequestrum | 1 (100.00%) |
Plastic Surgery | 1 (100.00%) |
Pain In Jaw | 1 (100.00%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
